Targeting the WSB2–NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors
Anti-apoptotic B-cell lymphoma-2 (BCL-2) family proteins are frequently overexpressed in various cancers, playing a pivotal role in cancer initiation and progression, as well as intrinsic or acquired resistance to therapy. Although inhibitors targeting BCL-2, such as Venetoclax, have shown efficacy...
Saved in:
| Main Authors: | Dongyue Jiao, Kun Chang, Jiamin Jin, Yingji Chen, Mo Ren, Yucong Zhang, Kun Gao, Yaoting Xu, Lixin Wang, Chenji Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
eLife Sciences Publications Ltd
2025-07-01
|
| Series: | eLife |
| Subjects: | |
| Online Access: | https://elifesciences.org/articles/98372 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A new era in cancer therapy: targeting the Proteasome-Bcl-2 axis
by: Sourabh Soni, et al.
Published: (2025-08-01) -
SFXN2 contributes mitochondrial dysfunction-induced apoptosis as a substrate of Parkin
by: Shishi Luo, et al.
Published: (2025-08-01) -
A clinical case of the effective combined use of BCL-2 and PI3K inhibitors in the treatment of a patient with an unfavorable chronic lymphocytic leukemia with transformation into diffuse large B-cell lymphoma (Richter’s syndrome)
by: O. A. Rukavitsyn, et al.
Published: (2022-11-01) -
Ubiquitin and regulation of apoptosis in Jurkat cells
by: O. L. Nosareva, et al.
Published: (2018-09-01) -
USP18 attenuates endoplasmic reticulum stress via the PERK-eIF2α-ATF4 axis to reduce apoptosis in hepatocellular carcinoma cells
by: Lin Li, et al.
Published: (2025-05-01)